What Is Zura Bio Limited (ZURA) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Zura Bio Limited's intrinsic value is estimated at a composite fair value of $4.71. Trading at $5.39, the stock is approaching fair value or slight overvaluation (implied return of -12.6%), as 5 of 7 models suggest limited further upside. Notably, Sentiment SOTP sees the most upside at +60.4% (fair value: $8.65), while ML-RIV is the most conservative at -96.9% ($0.17). The spread between these extremes — +157.4% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About ZURA?
7 of 13 models are currently active for ZURA. Of these, 2 models suggest upside while 5 models suggest overvaluation. The Bayesian DCF estimates ZURA's intrinsic value at $3.45, implying -35.9% downside from the current price. See which stocks rank higher →
How Does ZURA Rank in Biological Products, (No Diagnostic Substances)?
Among 134 Biological Products, (No Diagnostic Substances) stocks, ZURA ranks #91 by Quality of Company score. CirclFi's QOC score of 4.6/10 evaluates 32 fundamental signals. A score of 4.6 reflects mixed fundamentals.
See all Most Undervalued Biological Products, (No Diagnostic Substances) Stocks →
Zura Bio Limited operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is ZURA a Value Trap?
CirclFi's Value Trap algorithm assigns ZURA a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
7 of 13 models are active for Zura Bio Limited. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Zura Bio Limited scores 4.6 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +157.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every ZURA valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across ZURA's 7 active models, average confidence is 26%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad